ArticleExperimental hematology2019

Compounds targeting class II histone deacetylases do not cause panHDACI-associated impairment of megakaryocyte differentiation.

Damir Simic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.